Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Lithium Accumulates in Neurogenic Brain Regions as Revealed by High Resolution Ion Imaging.

Zanni G, Michno W, Di Martino E, Tjärnlund-Wolf A, Pettersson J, Mason CE, Hellspong G, Blomgren K, Hanrieder J.

Sci Rep. 2017 Jan 18;7:40726. doi: 10.1038/srep40726.

2.

Effects of Lithium Monotherapy for Bipolar Disorder on Gene Expression in Peripheral Lymphocytes.

Anand A, McClintick JN, Murrell J, Karne H, Nurnberger JI, Edenberg HJ.

Mol Neuropsychiatry. 2016 Oct;2(3):115-123. Epub 2016 Jun 29.

PMID:
27867936
3.

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.

Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR.

BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x.

4.

Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.

Lee RS, Pirooznia M, Guintivano J, Ly M, Ewald ER, Tamashiro KL, Gould TD, Moran TH, Potash JB.

Transl Psychiatry. 2015 Jul 14;5:e600. doi: 10.1038/tp.2015.90.

5.

Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Toker L, Bersudsky Y, Plaschkes I, Chalifa-Caspi V, Berry GT, Buccafusca R, Moechars D, Belmaker RH, Agam G.

Neuropsychopharmacology. 2014 Jan;39(2):319-28. doi: 10.1038/npp.2013.194. Epub 2013 Aug 8.

6.

Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.

Ramadan E, Basselin M, Chang L, Chen M, Ma K, Rapoport SI.

J Neuroimmune Pharmacol. 2012 Sep;7(3):701-13. doi: 10.1007/s11481-012-9381-0. Epub 2012 Jul 4.

7.

A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response.

McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK.

PLoS One. 2012;7(2):e32091. doi: 10.1371/journal.pone.0032091. Epub 2012 Feb 22.

8.

Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.

Liu ZH, Huang T, Smith CB.

Neurobiol Dis. 2012 Mar;45(3):1145-52. doi: 10.1016/j.nbd.2011.12.037. Epub 2011 Dec 29.

9.

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.

Gupta A, Schulze TG, Nagarajan V, Akula N, Corona W, Jiang XY, Hunter N, McMahon FJ, Detera-Wadleigh SD.

Pharmacogenomics J. 2012 Aug;12(4):328-41. doi: 10.1038/tpj.2011.9. Epub 2011 Mar 8.

10.

Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Squassina A, Manchia M, Del Zompo M.

Hum Genomics Proteomics. 2010 Aug 3;2010:159761. doi: 10.4061/2010/159761.

11.

Lithium: a key to the genetics of bipolar disorder.

Cruceanu C, Alda M, Turecki G.

Genome Med. 2009 Aug 19;1(8):79. doi: 10.1186/gm79.

12.

Bipolar disorder and mechanisms of action of mood stabilizers.

Rapoport SI, Basselin M, Kim HW, Rao JS.

Brain Res Rev. 2009 Oct;61(2):185-209. doi: 10.1016/j.brainresrev.2009.06.003. Epub 2009 Jun 23. Review.

13.
14.

Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.

Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, Choudary P, Atz M, Shao L, Neal C, Walsh DM, Burmeister M, Speed T, Myers R, Jones EG, Watson SJ, Akil H, Bunney WE.

Mol Psychiatry. 2006 Jul;11(7):615, 663-79. Epub 2006 Apr 25.

15.

Gene-environment interaction and the genetics of depression.

Lesch KP.

J Psychiatry Neurosci. 2004 May;29(3):174-84. Review.

Supplemental Content

Support Center